Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Nio Stock Is in Bubble Territory But There’s More Room to Run

There’s no denying that Nio stock is one of the top performers of 2020. At the same time, there’s also no denying that shares are starting to enter bubble territory, if they aren’t there already.

Can Cytonics Pivot Successfully to Covid-19 Therapeutics?

Most equity crowdfunding investors know Cytonics stock as a play on an osteoarthritis solution. However, this could be a big name in the Covid-19 therapeutic search.

Why Science Isn’t Enough for Velodyne

Velodyne stock is another name to consider for your autonomous portfolio. But one of the biggest risks is that the science is moving too far ahead for societal infrastructures to accommodate.

7 Short-Term Stocks to Make a Quick Buck

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

9 Stocks to Buy for a Wild Ride in November

With rising coronavirus hospitalizations dominating headlines, investors will shift back toward a pandemic mentality. Here are nine stocks to buy to capitalize on this trend.